##gff-version 3
##sequence-region Q9UJM3 1 462
Q9UJM3	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q9UJM3	UniProtKB	Chain	2	462	.	.	.	ID=PRO_0000096487;Note=ERBB receptor feedback inhibitor 1	
Q9UJM3	UniProtKB	Region	334	363	.	.	.	Note=Interaction with EGFR and ERBB2 and regulation of EGFR activation	
Q9UJM3	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q9UJM3	UniProtKB	Modified residue	127	127	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99JZ7	
Q9UJM3	UniProtKB	Modified residue	131	131	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99JZ7	
Q9UJM3	UniProtKB	Modified residue	251	251	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:21406692,PMID:23186163,PMID:24275569	
Q9UJM3	UniProtKB	Modified residue	273	273	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q9UJM3	UniProtKB	Modified residue	302	302	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q99JZ7	
Q9UJM3	UniProtKB	Modified residue	461	461	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:21406692;Dbxref=PMID:18669648,PMID:18691976,PMID:21406692	
Q9UJM3	UniProtKB	Natural variant	109	109	.	.	.	ID=VAR_063039;Note=D->N;Dbxref=dbSNP:rs34781518	
Q9UJM3	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_050975;Note=I->L;Dbxref=dbSNP:rs34974993	
Q9UJM3	UniProtKB	Mutagenesis	346	346	.	.	.	Note=Abolishes inhibition of EGFR activity. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18046415;Dbxref=PMID:18046415	
Q9UJM3	UniProtKB	Mutagenesis	352	352	.	.	.	Note=Abolishes inhibition of EGFR activity. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18046415;Dbxref=PMID:18046415	
Q9UJM3	UniProtKB	Mutagenesis	358	358	.	.	.	Note=Abolishes inhibition of EGFR activity. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18046415;Dbxref=PMID:18046415	
Q9UJM3	UniProtKB	Sequence conflict	7	7	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UJM3	UniProtKB	Sequence conflict	36	36	.	.	.	Note=S->C;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UJM3	UniProtKB	Helix	342	344	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZJV	
Q9UJM3	UniProtKB	Turn	356	358	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZJV	
Q9UJM3	UniProtKB	Beta strand	378	382	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZJV	
Q9UJM3	UniProtKB	Beta strand	390	397	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4ZJV	
